NCT01491594 Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia Status TERMINATED Phase PHASE1
NCT01489943 A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01488565 A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia Status COMPLETED Phase PHASE2
NCT01485445 Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination Status COMPLETED Phase PHASE1
NCT01485406 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers Status COMPLETED Phase PHASE1
NCT01485237 Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization Status COMPLETED Phase N/A
NCT01485185 Gabapentin and Donepezil Combination on Experimental Human Pain Models Status COMPLETED Phase PHASE1
NCT01485172 A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease Status COMPLETED Phase PHASE4
NCT01484496 A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE3
NCT01484093 Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01481220 Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE1
NCT01480622 Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01480609 Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite Status COMPLETED Phase PHASE1
NCT01480284 Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue Status COMPLETED Phase PHASE3
NCT01480271 An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. Status COMPLETED Phase PHASE1
NCT01480245 Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE3
NCT01479491 Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan Status COMPLETED Phase N/A